SMMT Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own SMMT shares is 239, representing 11.73% of the company's common stock.

ALPS ADVISORS INC, in the last quarter, reduced its stake in SMMT by -7.04% restricting it's holding to 494.92 thousand shares of worth nearly $2.05M. JPMORGAN CHASE & CO also lessened -15.71% of the SMMT shares from its portfolio, reducing its holding to 249.67 thousand shares of worth $1.03M. CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM also shunned SMMT shares holding by -3.91% last quarter which brought its holding to 137.65 thousand shares worth $569.85K.

As per its latest 13F filing, WELLINGTON MANAGEMENT GROUP LLP increased its stake in SMMT by 100% in the last quarter. The institutional holder raised its holding to 297.62 thousand shares having worth more than $1.23M. STEWARD PARTNERS INVESTMENT ADVISORY, LLC also added 1.08% more shares of SMMT to its portfolio, raising its holding to 606.5 thousand shares of worth $2.51M. BANK OF MONTREAL /CAN/ also increased its SMMT shares holding by 2,141.7% which brought its holding to 589.57 thousand shares worth $2.72M.

The insider with the most stakes in SMMT is DUGGAN ROBERT W , Chief Executive Officer at the company. Additionally, SMMT stock is highly held by Chief Operating Officer Soni Manmeet Singh and Co-CEO & President Zanganeh Maky among others.

Company executives, directors, and other insiders own 84.36% percent of Summit Therapeutics Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which SMMT insiders have sold stock, totaling 0 shares. Insiders that have sold shares include POWELL DAVID JONATHAN.

There have been 0 transaction(s) during the past 6-months in which Summit Therapeutics Inc. insiders have bought stock, totalling 0 shares

Around 0 Summit Therapeutics Inc. shares are held by insiders, which represents about 84.36% of SMMT stock.

SMMT Chief Executive Officer, DUGGAN ROBERT W holds the largest portfolio of the company's shares. SMMT shares owned by DUGGAN total nearly 552.35 million.

WELLINGTON MANAGEMENT GROUP LLP is the largest institutional owner in SMMT which holds 297.62 thousand shares worth $1.23M or 0.05% of the total SMMT shares outstanding followed by STEWARD PARTNERS INVESTMENT ADVISORY, LLC with ownership of 606.5 thousand shares representing 0.1% of the SMMT ownership. BANK OF MONTREAL /CAN/ is the third largest stakeholder with 589.57 thousand shares or 0.1% of the ownership worth more than $2.72M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the SMMT is concerned, it is a stock which is optionable.

Number of SMMT shares short is 19.94M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 737.45M shares of SMMT are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, SMMT has 105.06M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for SMMT is 9.05.